
By BY STEPHANIE NOLEN from NYT Health Regulatory hurdles and supply chain issues could slow efforts to produce generic versions of Merck’s antiviral molnupiravir for developing nations, despite licensing agreements. https://ift.tt/3AZ0ZG8

By BY BENJAMIN MUELLER AND JAN HOFFMAN from NYT Health Nationwide, the number of kindergartners with the required shots fell below the targ...
Hiç yorum yok:
Yorum Gönder